The Secret “Spice”: An Undetectable Toxic Cause of Seizure
- 9 September 2011
- journal article
- Published by SAGE Publications in The Neurohospitalist
- Vol. 1 (4), 182-186
- https://doi.org/10.1177/1941874411417977
Abstract
Neurologists and emergency department physicians are frequently involved in the comprehensive evaluation of a first generalized seizure. An important aspect of this evaluation is a detailed history which can identify a provoked seizure secondary to drug toxicity and hence avoid unnecessary treatment with antiepileptic drugs. “Spice” is an umbrella term for a variety of synthetic cannabinoid products whose inhalation has been associated with an increasing number of toxic side effects resulting in emergency department visits. These side effects (including psychosis, tachyarrhythmia, and seizures) are not typically seen with marijuana ( Cannabis sativa) use. We report 2 patients with no prior history of neurological disease that experienced their first generalized tonic–clonic seizure after smoking Spice. The mechanism behind the possible proconvulsant effect of synthetic cannabinoids is not known, but it may be due to their effects at the cannabinoid receptor CB1. Although the US Drug Enforcement Administration placed 5 synthetic cannabinoids into schedule 1 for a 12-month period beginning March 2011, new Spice products containing different synthetic cannabinoids continue to emerge. Because synthetic cannabinoids are not detectable on commercial drug screens it is important that neurologists and emergency department physicians consider Spice inhalation in their differential diagnosis of a first generalized seizure.Keywords
This publication has 13 references indexed in Scilit:
- The emergence and analysis of synthetic cannabinoidsDrug Testing and Analysis, 2011
- Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samplesJournal of Mass Spectrometry, 2011
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In VivoThe Journal of pharmacology and experimental therapeutics, 2009
- Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizureEpilepsia, 2009
- An introduction to the endocannabinoid system: from the early to the latest conceptsBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- First seizure definitions and worldwide incidence and mortalityEpilepsia, 2008
- Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature.2007
- Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampusNeuroscience, 2001
- Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effectsEuropean Journal of Pharmacology, 2001
- Newly Diagnosed Unprovoked Epileptic Seizures: Presentation at Diagnosis in CAROLE StudyEpilepsia, 2001